InvestorsHub Logo
Followers 15
Posts 1218
Boards Moderated 0
Alias Born 11/01/2007

Re: None

Monday, 01/13/2014 4:43:31 PM

Monday, January 13, 2014 4:43:31 PM

Post# of 48316
Hey guys, been long ONCS since .29 and viewing this board from afar for a couple months. Great info / dialogue from the regulars and one of the better biotech boards.

Obviously, the addition of Dr Pierce has instilled additional confidence for me in ONCS.

Sure it's been mentioned, But it shouldn't be stressed enough the fact that management has chosen to bypass a R/S. This indicates the confidence that management has on the catalysts / pending data. In addition, I don't see what I would call PR fluff that many biotech stocks use to "pump" the stock to make up for deficiencies.

Look forward to the catalysts. It's really hard to believe how undervalued this company is when after seeing how disruptive this technology is. I don't see safety really being one of the issues with the FDA process...